Log in

NYSE:ABBVAbbVie News Headlines

$97.94
-1.34 (-1.35 %)
(As of 07/9/2020 04:00 PM ET)
Add
Compare
Today's Range
$96.81
Now: $97.94
$99.78
50-Day Range
$89.98
MA: $94.78
$99.35
52-Week Range
$62.55
Now: $97.94
$100.69
Volume5.81 million shs
Average Volume7.34 million shs
Market Capitalization$144.63 billion
P/E Ratio17.33
Dividend Yield4.75%
Beta0.86

Headlines

AbbVie (NYSE ABBV) News Headlines

Source:
DateHeadline
AbbVie 2020: Company Background, Recent Earnings Review, Company Forecast, Company Profile and Clinical Trial Overview - PRNewswireAbbVie 2020: Company Background, Recent Earnings Review, Company Forecast, Company Profile and Clinical Trial Overview - PRNewswire
www.prnewswire.com - July 10 at 12:07 AM
FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with SpasticityFDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity
finance.yahoo.com - July 9 at 7:07 PM
AbbVie Stands to Benefit from Affluenza - NasdaqAbbVie Stands to Benefit from Affluenza - Nasdaq
www.nasdaq.com - July 9 at 9:06 AM
Carlos Alban Sells 53,325 Shares of AbbVie Inc (NYSE:ABBV) StockCarlos Alban Sells 53,325 Shares of AbbVie Inc (NYSE:ABBV) Stock
www.marketbeat.com - July 9 at 5:52 AM
Better Buy: AbbVie vs. BiogenBetter Buy: AbbVie vs. Biogen
finance.yahoo.com - July 8 at 8:59 AM
6 Stocks to Wade Through the Spike in Coronavirus Cases6 Stocks to Wade Through the Spike in Coronavirus Cases
finance.yahoo.com - July 8 at 8:59 AM
AbbVie Stands to Benefit from Affluenza - InvestorPlaceAbbVie Stands to Benefit from Affluenza - InvestorPlace
investorplace.com - July 7 at 7:03 PM
AbbVie to Host Second-Quarter 2020 Earnings Conference Call - Yahoo FinanceAbbVie to Host Second-Quarter 2020 Earnings Conference Call - Yahoo Finance
finance.yahoo.com - July 7 at 7:03 PM
AbbVie 2020: Company Background, Recent Earnings Review, Company Forecast, Company Profile and Clinical Trial Overview - Yahoo FinanceAbbVie 2020: Company Background, Recent Earnings Review, Company Forecast, Company Profile and Clinical Trial Overview - Yahoo Finance
finance.yahoo.com - July 7 at 2:03 PM
Should holders of Abbvie Inc expect a dividend payout?Should holders of Abbvie Inc expect a dividend payout?
uk.finance.yahoo.com - July 7 at 9:02 AM
Global Medical Aesthetics Market (2020 to 2024) - Featuring 3M, AbbVie & Danaher Among Others - ResearchAndMarkets.comGlobal Medical Aesthetics Market (2020 to 2024) - Featuring 3M, AbbVie & Danaher Among Others - ResearchAndMarkets.com
www.businesswire.com - July 7 at 9:02 AM
Biopharmaceutical Oral Drug Delivery Market COVID-19 Impact Forecast Study By Global Countries Data (2020-2029) | AbbVie and AmgenBiopharmaceutical Oral Drug Delivery Market COVID-19 Impact Forecast Study By Global Countries Data (2020-2029) | AbbVie and Amgen
www.marketwatch.com - July 7 at 9:02 AM
Evolus Botox Rival Loses First Round Over AbbVie’s AllerganEvolus Botox Rival Loses First Round Over AbbVie’s Allergan
www.msn.com - July 7 at 9:02 AM
Shareholders Of AbbVie (NYSE:ABBV) Must Be Happy With Their 75% ReturnShareholders Of AbbVie (NYSE:ABBV) Must Be Happy With Their 75% Return
finance.yahoo.com - July 7 at 9:02 AM
AbbVie to Host Second-Quarter 2020 Earnings Conference CallAbbVie to Host Second-Quarter 2020 Earnings Conference Call
finance.yahoo.com - July 7 at 9:02 AM
AbbVie 2020: Company Background, Recent Earnings Review, Company Forecast, Company Profile and Clinical Trial OverviewAbbVie 2020: Company Background, Recent Earnings Review, Company Forecast, Company Profile and Clinical Trial Overview
www.prnewswire.com - July 7 at 7:10 AM
4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger - Yahoo Finance4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger - Yahoo Finance
finance.yahoo.com - July 6 at 6:49 PM
Musculoskeletal Disorders Therapeutics Market Set New Growth Story For Future Development By 2029 | Pfizer and AbbVieMusculoskeletal Disorders Therapeutics Market Set New Growth Story For Future Development By 2029 | Pfizer and AbbVie
www.marketwatch.com - July 6 at 1:49 PM
4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger4 Reasons to Own AbbVie Stock as Coronavirus Woes Linger
finance.yahoo.com - July 6 at 1:49 PM
AbbVie Company Profile 2020: Explores the Companys Prescription Pharmaceutical Performance and Outlook Over 2019-2029 - GlobeNewswireAbbVie Company Profile 2020: Explores the Company's Prescription Pharmaceutical Performance and Outlook Over 2019-2029 - GlobeNewswire
www.globenewswire.com - July 6 at 8:48 AM
AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run? - Yahoo FinanceAbbVie (ABBV) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
finance.yahoo.com - July 5 at 10:57 PM
AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run? - NasdaqAbbVie (ABBV) Hits Fresh High: Is There Still Room to Run? - Nasdaq
www.nasdaq.com - July 3 at 1:23 PM
3 Reasons AbbVie Could Make You Rich - Seeking Alpha3 Reasons AbbVie Could Make You Rich - Seeking Alpha
seekingalpha.com - July 3 at 1:23 PM
AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run?AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run?
finance.yahoo.com - July 3 at 1:23 PM
3 Reasons AbbVie Could Make You Rich3 Reasons AbbVie Could Make You Rich
seekingalpha.com - July 3 at 10:46 AM
Better Coronavirus Stock: Eli Lilly or AbbVie? - Motley FoolBetter Coronavirus Stock: Eli Lilly or AbbVie? - Motley Fool
www.fool.com - July 3 at 8:21 AM
Better Coronavirus Stock: Eli Lilly or AbbVie?Better Coronavirus Stock: Eli Lilly or AbbVie?
finance.yahoo.com - July 3 at 8:21 AM
Top Ranked Income Stocks to Buy for July 2ndTop Ranked Income Stocks to Buy for July 2nd
finance.yahoo.com - July 2 at 2:26 PM
Buy Pharma Giant AbbVie Stock for Growth, Income & Coronavirus Safety - Yahoo FinanceBuy Pharma Giant AbbVie Stock for Growth, Income & Coronavirus Safety - Yahoo Finance
finance.yahoo.com - July 1 at 6:40 PM
What Makes AbbVie (ABBV) a New Strong Buy Stock - Yahoo FinanceWhat Makes AbbVie (ABBV) a New Strong Buy Stock - Yahoo Finance
finance.yahoo.com - July 1 at 6:40 PM
Buy Pharma Giant AbbVie Stock for Growth, Income & Coronavirus SafetyBuy Pharma Giant AbbVie Stock for Growth, Income & Coronavirus Safety
finance.yahoo.com - July 1 at 6:40 PM
What Makes AbbVie (ABBV) a New Strong Buy StockWhat Makes AbbVie (ABBV) a New Strong Buy Stock
finance.yahoo.com - July 1 at 1:39 PM
AbbVie Combo Doesn’t Benefit Covid Patients, Study FindsAbbVie Combo Doesn’t Benefit Covid Patients, Study Finds
www.msn.com - June 30 at 7:05 PM
3 Dividend Stocks to Buy for Second Half of 2020 for Coronavirus Safety3 Dividend Stocks to Buy for Second Half of 2020 for Coronavirus Safety
finance.yahoo.com - June 30 at 7:04 PM
AbbVie Inc (NYSE:ABBV) Receives Average Recommendation of "Buy" from BrokeragesAbbVie Inc (NYSE:ABBV) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - June 30 at 2:04 PM
AbbVie Combo Doesn’t Benefit Covid Patients, Study Finds - BloombergAbbVie Combo Doesn’t Benefit Covid Patients, Study Finds - Bloomberg
www.bloomberg.com - June 29 at 11:47 PM
Were Hedge Funds Right About Piling Into AbbVie Inc (ABBV)? - Yahoo FinanceWere Hedge Funds Right About Piling Into AbbVie Inc (ABBV)? - Yahoo Finance
finance.yahoo.com - June 29 at 1:46 PM
Were Hedge Funds Right About Piling Into AbbVie Inc (ABBV)?Were Hedge Funds Right About Piling Into AbbVie Inc (ABBV)?
finance.yahoo.com - June 29 at 1:46 PM
AbbVie (NYSE:ABBV) PT Raised to $110.00AbbVie (NYSE:ABBV) PT Raised to $110.00
www.americanbankingnews.com - June 29 at 9:30 AM
Mizuho Raises AbbVie (NYSE:ABBV) Price Target to $110.00Mizuho Raises AbbVie (NYSE:ABBV) Price Target to $110.00
www.marketbeat.com - June 29 at 8:54 AM
AbbVie: This Blue Chip Name Offers Strong Double Digit Total Returns - Seeking AlphaAbbVie: This Blue Chip Name Offers Strong Double Digit Total Returns - Seeking Alpha
seekingalpha.com - June 28 at 12:57 PM
AbbVie: This Blue Chip Name Offers Strong Double Digit Total ReturnsAbbVie: This Blue Chip Name Offers Strong Double Digit Total Returns
seekingalpha.com - June 28 at 12:34 PM
FDA Rejects AbbVies Macular Degeneration Drug Abicipar PegolFDA Rejects AbbVie's Macular Degeneration Drug Abicipar Pegol
www.fool.com - June 28 at 7:56 AM
AbbVie: Stock Remains Extremely Attractive Despite Recent Price AppreciationAbbVie: Stock Remains Extremely Attractive Despite Recent Price Appreciation
seekingalpha.com - June 26 at 12:48 PM
AbbVies Eye Disorder Candidate Gets Complete Response LetterAbbVie's Eye Disorder Candidate Gets Complete Response Letter
finance.yahoo.com - June 26 at 12:48 PM
August 7th Options Now Available For AbbVie (ABBV)August 7th Options Now Available For AbbVie (ABBV)
www.nasdaq.com - June 26 at 7:40 AM
AbbVie: FDA Issues Complete Response Letter To BLA For Abicipar PegolAbbVie: FDA Issues Complete Response Letter To BLA For Abicipar Pegol
www.nasdaq.com - June 26 at 7:40 AM
BRIEF-Allergan, An Abbvie Company, And Molecular Partners Receive CRL From FDA On Biologics License Application For Abicipar PegolBRIEF-Allergan, An Abbvie Company, And Molecular Partners Receive CRL From FDA On Biologics License Application For Abicipar Pegol
www.reuters.com - June 26 at 7:40 AM
How gene therapy and CRISPR are helping to cure blindnessHow gene therapy and CRISPR are helping to cure blindness
finance.yahoo.com - June 25 at 3:05 PM
Sosei, AbbVie sign drug discovery deal worth up to $1 billionSosei, AbbVie sign drug discovery deal worth up to $1 billion
finance.yahoo.com - June 25 at 10:03 AM
This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.